Cargando…
Cdc2-like kinase 2 is a key regulator of the cell cycle via FOXO3a/p27 in glioblastoma
Cdc2-like kinase 2 (CLK2) is known as a regulator of RNA splicing that ultimately controls multiple physiological processes. However, the function of CLK2 in glioblastoma progression has not been described. Reverse-phase protein array (RPPA) was performed to identify proteins differentially expresse...
Autores principales: | Park, Soon Young, Piao, Yuji, Thomas, Craig, Fuller, Gregory N., de Groot, John F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042015/ https://www.ncbi.nlm.nih.gov/pubmed/27050366 http://dx.doi.org/10.18632/oncotarget.8471 |
Ejemplares similares
-
mir-218-2 promotes glioblastomas growth, invasion and drug resistance by targeting CDC27
por: Feng, Zhuoying, et al.
Publicado: (2016) -
PAR proteins direct asymmetry of the cell cycle regulators Polo-like kinase and Cdc25
por: Rivers, David M., et al.
Publicado: (2008) -
Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice
por: de Groot, John F., et al.
Publicado: (2010) -
Structural Basis for the Selective Inhibition of Cdc2-Like Kinases by CX-4945
por: Lee, Joo Youn, et al.
Publicado: (2019) -
Cdc2-like kinases: structure, biological function, and therapeutic targets for diseases
por: Song, Mengqiu, et al.
Publicado: (2023)